Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Large Is the m-RNA Synthesis Service Market Expected to Be in 2029?

The market size for m-rna synthesis service has seen a robust expansion in preceding years. It is projected to inflate from $4.54 billion in 2024 to $4.99 billion in 2025, marking an annual compound growth rate (CAGR) of 9.9%. The historical growth can be credited to an escalating demand for tailor-made medicine and gene treatments, proliferation of clinical trials, increasing occurrence of infectious diseases, augmented investment in biotechnology, and a rising emphasis on developing vaccines.

Significant growth is predicted in the m-rna synthesis service market over the next several years, with a projected increase to $7.22 billion in 2029 at a compound annual growth rate (CAGR) of 9.7%. Factors that may drive this growth include a rise in the uptake of mRNA therapies, increasing uses of mRNA technology, a heightened emphasis on mRNA therapeutics for autoimmune diseases, a continuous surge in the need for mRNA-based vaccines, and an increased demand for custom mRNA synthesis solutions. Key emerging trends for this period are progress in RNA polymerase enzyme engineering, the development of next-gen mRNA vaccines, automation processes in mRNA production, bespoke mRNA therapies, and the application of AI and machine learning in the design of mRNA.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24611&type=smp

What Are The Contributors To Demand In The m-RNA Synthesis Service Market?

The mRNA synthesis service market is anticipated to grow with the rising emphasis on personalized medicine. Personalized medicine employs a medical strategy that customizes treatment and healthcare choices based on an individual’s genetics, lifestyle, and surroundings. Given the latest advancements in genomic sequencing which assist in accurate identification of unique genetic variations related to disease and treatment response, personalized medicine is on the rise. The use of mRNA synthesis services enhances the personalized medicine approach by facilitating quick and accurate creation of mRNA-based treatments customized to a person’s genetic characteristics, thereby encouraging more effective and targeted treatments. For example, the Personalized Medicine Coalition, an American non-profit, reported in February 2024 that in 2023, the FDA greenlighted 16 new personalized treatments for patients with rare diseases, a significant bump from 6 in 2022. Of the treatments, seven were cancer medications, and three were aimed at other illnesses and conditions. Consequently, the surge in personalized medicine practice is propelling the mRNA synthesis service market growth.

What Segmentation Categories Are Included In The m-RNA Synthesis Service Market Analysis?

The m-rna synthesis service market covered in this report is segmented –

1) By Type: mRNA Vaccine Synthesis, mRNA Drug Synthesis

2) By Application Area: Vaccine Development, Therapeutic Development, Research and Development, Diagnostics

3) By End-user Industry: Pharmaceutical Companies, Biotechnology Firms, Academic And Research Institutions, Contract Research Organizations (CROs)

Subsegments:

1) By mRNA Vaccine Synthesis: Infectious Disease Vaccines, Cancer Vaccines, Personalized Vaccines

2) By mRNA Drug Synthesis: Protein Replacement Therapies, Gene Editing Therapeutics, Cell Therapy Support

What Upcoming Trends Are Expected To Impact The m-RNA Synthesis Service Market Globally?

The mRNA synthesis service market is seeing a focus from key players in the development of original solutions such as RNA polymerase enhancements designed to optimize the effectiveness, output, and safety of mRNA synthesis. These innovations in RNA polymerase refer to the creation of upgraded enzymes that amplify the transcription process, diminish potential drawbacks like the formation of double-stranded RNA, and ultimately improve the quality of mRNA for therapeutics and vaccines. For example, Primrose Bio Inc., a biotech firm based in the US, unveiled its Prima RNApols in March 2025, which were designed to increase both the efficiency and scalability of mRNA synthesis. This enzyme has the capability for improved processivity and high-fidelity transcription, which allows it to generate longer and more stable mRNA strands with decreased chances of errors. It’s remarkable effectiveness in in vitro transcription systems reduces impurities and elevates the total yield, providing a dependable and scalable option for companies involved in the production of mRNA-based drugs. This evolution is especially beneficial in the expanding sector of personalized medicine where accurate and efficient mRNA synthesis is vital.

Who Are The Top-Ranked Companies In The m-RNA Synthesis Service Market Today?

Major companies operating in the m-rna synthesis service market are Thermo Fisher Scientific Inc., Danaher Corporation, AGC Biologics Inc., Eurofins Scientific SE, Lonza Group AG, Catalent Inc., Samsung Biologics Co. Ltd., WuXi Biologics (Cayman) Inc., GenScript Biotech Corporation, Azenta Inc., Genewiz Inc., New England Biolabs Inc., TransGen Biotech Co. Ltd., Creative Biolabs Inc., Bioneer Corporation, Aldevron LLC, eTheRNA immunotherapies NV, Bio-Synthesis Inc., TriLink BioTechnologies LLC, APExBIO Technology LLC

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/m-rna-synthesis-service-global-market-report

How Is m-RNA Synthesis Service Market Adoption Varying Across Different Regions And Sectors?

North America was the largest region in the m-RNA synthesis service market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the m-rna synthesis service market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=24611&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model